EgiliusL. H.SpieringsMD
Neurology • Waltham, MAHeadache
Medical Director, Greater Boston Headache Center, Boston Advanced Medicine, Waltham, Massachusetts; Retired Clinical Professor of Neurology and Craniofacial Pain, Tufts University Schools of Medicine and Dental Medicine; Former Associate Clinical Professor of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
Dr. Spierings is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
85 First Avenue
Waltham, MA 02452Phone+1 617-744-1310Fax+1 617-744-1285- Is this information wrong?
Summary
- Dr. Egilius Spierings is a neurologist in Waltham, MA. He received his medical degree from Erasmus University Rotterdam Faculty of Medicine and has been in practice 39 years. He also speaks Dutch. He specializes in headache and face pain and is experienced in clinical-trial research. He has more than 100 publications and over 500 citings.
Education & Training
Faculty of Medicine, Erasmus University, RotterdamPhD, Pharmacology, 1978 - 1980
Erasmus University Rotterdam Faculty of MedicineClass of 1978
Certifications & Licensure
MA State Medical License 1987 - 2025- Royal Netherlands Medical Association (Neurology), 1986; Board of Registration in Medicine, Commonwealth of Massachusetts, 1986
Clinical Trials
- Staccato Loxapine in Migraine (in Clinic) Start of enrollment: 2007 Jun 01
- Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone Start of enrollment: 2007 Aug 01
- Staccato Prochlorperazine in Migraine (in Clinic) Start of enrollment: 2005 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsCelecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review.Stephen Silberstein, Egilius L H Spierings, Todd Kunkel> ;Pain and Therapy. 2023 Oct 1
- 5 citationsCardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled st...Timothy R. Smith, Egilius L.H. Spierings, Roger Cady, Joe Hirman, Anders Ettrup, Vivienne Shen> ;The Journal of Headache and Pain. 2021 Nov 25
- 7 citationsImprovements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inade...Egilius L.H. Spierings, Xiaoping Ning, Verena Ramirez Campos, Joshua M. Cohen, Steve Barash, Dawn C. Buse> ;Headache. 2021 Oct 1
- Join now to see all
Press Mentions
Alder BioPharmaceuticals® to Present New Data Further Highlighting Eptinezumab's Efficacy Profile for Migraine Prevention at American Headache Society MeetingJune 20th, 2018
Zosano Presents Additional Data from ZOTRIP Study at American Headache Society, Demonstrating Positive Results for Pain Freedom and Sustained Pain FreedomJune 12th, 2017
Other Languages
- Dutch
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
